*4.4.4 Conclusion*

1.PDP is clinically effective for the treatment of PD and GAD, comparing with the WLC group.

3.PDP is effective in the PT + PPT format, so it can be used for a successful

4.UH produces a distinct mindfulness effect comparable to that for mindfulness-

therapy on patients recurrent and resistant to PPT.

**Scale MPT group (***n* **= 32) PT + PPT group (***n* **= 20) M SD d (before-**

*The Integrative Theory of Hypnosis in the Light of Clinical Hypnotherapy*

*DOI: http://dx.doi.org/10.5772/intechopen.92761*

At baseline 1.56 0.64 1.81 1.06

At baseline 1.76 0.80 2.01 1.11

At baseline 1.21 0.41 1.42 0.86

At baseline 34.25 6.66 42.30 14.74

At baseline 52.69 8.10 58.90 11.19

At baseline 18.44 8.92 21.30 12.09

At baseline 45.38 24.95 54.20 25.99

At baseline 71.70 7.34 71.28 11.95

At baseline 3.85 0.75 3.97 0.67

**SCL-90 DEP**

**SCL-90 ANX**

**SCL-90 GSI**

**STAI-S**

**STAI-T**

**BDI**

**ShARS**

**FFMQ-SF**

**MAAS**

*1*

**Table 6.**

**65**

**after)**

At the end of treatment 0.62<sup>1</sup> 0.45 1.67 1.45<sup>6</sup> 1.05 0.34 1.03

At the end of treatment 0.66<sup>1</sup> 0.46 1.64 1.373,7 1.11 0.56 0.84

At the end of treatment 0.531 0.25 1.91 1.084,7 0.80 0.39 0.92

At the end of treatment 22.001 7.85 1.64 29.302,6 11.81 0.94 0.73

At the end of treatment 44.75<sup>1</sup> 5.32 1.13 53.503,5 11.61 0.46 0.97

At the end of treatment 8.441 4.99 1.35 11.60<sup>3</sup> 10.02 0.84 0.40

At the end of treatment 18.38<sup>1</sup> 10.38 1.38 27.903,6 19.19 1.11 0.62

At the end of treatment 80.60<sup>1</sup> 7.76 1.17 79.404 8.65 0.75 0.15

At the end of treatment 4.31<sup>1</sup> 0.65 0.64 4.402 0.80 0.57 0.12 *SCL-90 DEP, ANX, GSI—depression, anxiety and global severity index of symptom checklist 90; STAI-S—Spielberger Anxiety Inventory, state anxiety; STAI-T—Spielberger Anxiety Inventory, trait anxiety; BDI—Beck Depression Inventory; ShARS—Sheehan Clinical Anxiety Rating Scale; FFMQ-SF—Five-Factor Mindfulness Questionnaire, short version, total score; MAAS—Mindfulness Attention Awareness Scale; MPT group—monopsychotherapy group. PT + PPT group—psychotherapy + psychopharmacotherapy group*

**M SD d (before-**

**after)**

**d (between the groups)**

based CBT.

*with later psychopharmacotherapy withdrawal.*

*Treatment results in MPT and PT + PPT groups.*

*<sup>p</sup> <sup>&</sup>lt; 0.0001 (comparing to baseline figures). <sup>2</sup> <sup>p</sup> <sup>&</sup>lt; 0.001 (comparing to baseline figures). <sup>3</sup> <sup>p</sup> <sup>&</sup>lt; 0.005 (comparing to baseline figures). <sup>4</sup> <sup>p</sup> <sup>&</sup>lt; 0.01 (comparing to baseline figures). <sup>5</sup> <sup>p</sup> <sup>&</sup>lt; 0.001 (between the groups). <sup>6</sup> <sup>p</sup> <sup>&</sup>lt; 0.01 (between the groups). <sup>7</sup> p < 0.05 (between the groups).*

2.PDP is more effective in the MPT format than in PT + PPT format.


### *The Integrative Theory of Hypnosis in the Light of Clinical Hypnotherapy DOI: http://dx.doi.org/10.5772/intechopen.92761*

*SCL-90 DEP, ANX, GSI—depression, anxiety and global severity index of symptom checklist 90; STAI-S—Spielberger Anxiety Inventory, state anxiety; STAI-T—Spielberger Anxiety Inventory, trait anxiety; BDI—Beck Depression Inventory; ShARS—Sheehan Clinical Anxiety Rating Scale; FFMQ-SF—Five-Factor Mindfulness Questionnaire, short version, total score; MAAS—Mindfulness Attention Awareness Scale; MPT group—monopsychotherapy group. PT + PPT group—psychotherapy + psychopharmacotherapy group with later psychopharmacotherapy withdrawal.*

*1*

*<sup>p</sup> <sup>&</sup>lt; 0.0001 (comparing to baseline figures). <sup>2</sup>*

*<sup>p</sup> <sup>&</sup>lt; 0.001 (comparing to baseline figures). <sup>3</sup>*

*<sup>p</sup> <sup>&</sup>lt; 0.005 (comparing to baseline figures). <sup>4</sup>*

*<sup>p</sup> <sup>&</sup>lt; 0.01 (comparing to baseline figures). <sup>5</sup>*

*<sup>p</sup> <sup>&</sup>lt; 0.001 (between the groups). <sup>6</sup>*

*<sup>p</sup> <sup>&</sup>lt; 0.01 (between the groups). <sup>7</sup> p < 0.05 (between the groups).*

#### **Table 6.**

*4.4.4 Conclusion*

**SCL-90 DEP**

*Hypnotherapy and Hypnosis*

**SCL-90 ANX**

**SCL-90 GSI**

**STAI-S**

**STAI-T**

**BDI**

**ShARS**

**FFMQ-SF**

**MAAS**

*1*

**Table 5.**

**64**

the WLC group.

*<sup>p</sup> <sup>&</sup>lt; 0.0001 (comparing to baseline figures). <sup>2</sup> <sup>p</sup> <sup>&</sup>lt; 0.001 (comparing to baseline figures). <sup>3</sup> <sup>p</sup> <sup>&</sup>lt; 0.005 (comparing to baseline figures). <sup>4</sup> p < 0.02 (comparing to baseline figures).*

*Treatment results in PD and GAD groups.*

1.PDP is clinically effective for the treatment of PD and GAD, comparing with

2.PDP is more effective in the MPT format than in PT + PPT format.

**Scale PD group (***n* **= 29) GAD group (***n* **= 23)** *M* **SD d (before-**

At baseline 1.68 0.77 1.62 0.91

At baseline 2.09 0.81 1.54 1.00

At baseline 1.40 0.62 1.14 0.61

At baseline 36.80 10.83 38.09 11.71

At baseline 55.53 10.12 54.45 9.52

At baseline 19.93 10.89 19.00 9.49

At baseline 56.67 25.03 38.00 22.37

At baseline 72.46 9.02 70.28 9.68

At baseline 3.97 0.82 3.79 0.55

*psychopharmacotherapy group with later psychopharmacotherapy withdrawal.*

**after)**

At the end of treatment 0.82<sup>1</sup> 0.83 1.05 1.094 0.83 0.59 0.33

At the end of treatment 0.89<sup>1</sup> 0.72 1.52 0.98<sup>3</sup> 1.00 0.53 0.10

At the end of treatment 0.721 0.60 1.08 0.782 0.59 0.57 0.10

At the end of treatment 24.13<sup>1</sup> 9.77 1.20 25.72<sup>3</sup> 10.73 1.06 0.15

At the end of treatment 48.20<sup>1</sup> 10.66 0.69 48.00<sup>2</sup> 7.20 0.74 0.02

At the end of treatment 10.13<sup>1</sup> 8.29 0.99 9.00<sup>2</sup> 6.16 1.20 0.15

At the end of treatment 20.40<sup>1</sup> 13.78 1.75 24.273 16.56 0.67 0.25

At the end of treatment 79.18<sup>1</sup> 8.17 0.78 81.32<sup>3</sup> 7.95 1.20 0.27

At the end of treatment 4.45<sup>1</sup> 0.70 0.62 4.20<sup>3</sup> 0.71 0.61 0.35 *SCL-90 DEP, ANX, GSI—depression, anxiety and global severity index of symptom checklist 90; STAI-S—Spielberger Anxiety Inventory, state anxiety; STAI-T—Spielberger Anxiety Inventory, trait anxiety; BDI—Beck Depression Inventory; ShARS— Sheehan Clinical Anxiety Rating Scale; FFMQ-SF—Five-Factor Mindfulness Questionnaire, short version, total score; MAAS— Mindfulness Attention Awareness Scale; MPT group—monopsychotherapy group; PT + PPT group—psychotherapy +*

*M* **SD d (before-**

**after)**

**d (between the groups)**

*Treatment results in MPT and PT + PPT groups.*



**Table 7.**

*The comparison of PDP (UH) MBCT, MBSR efficiency, and mindfulness effect in therapy of anxiety disorders.*
